Works matching IS 00278874 AND DT 2010 AND VI 102 AND IP 24

Results: 22

How To Handle Positive Sentinel Nodes?
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1820, doi. 10.1093/jnci/djq522
By:
- Schmidt, Charlie
Publication type:
Article
IN THIS ISSUE.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1813, doi. 10.1093/jnci/djq519
Publication type:
Article
Reduction in Physician Reimbursement and Use of Hormone Therapy in Prostate Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1826, doi. 10.1093/jnci/djq417
By:
- Elliott, Sean P.;
- Jarosek, Stephanie L.;
- Wilt, Timothy J.;
- Virnig, Beth A.
Publication type:
Article
Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1845, doi. 10.1093/jnci/djq409
By:
- Bonilla, Luisa;
- Ben-Aharon, Irit;
- Vidal, Liat;
- Gafter-Gvili, Anat;
- Leibovici, Leonard;
- Stemmer, Salomon M.
Publication type:
Article
Response: Re: The Role of SATB1 in Breast Cancer Pathogenesis.
Published in:
2010
By:
- IORNS, ELIZABETH;
- HNATYSZYN, H. JAMES;
- SEO, PEARL;
- CLARKE, JENNIFER;
- WARD, TOBY;
- LIPPMAN, MARC E.
Publication type:
Letter
Decreased Physician Reimbursement for Hormone Therapy May Have Reduced Over-treatment of Low-risk Prostate Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq532
Publication type:
Article
Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1855, doi. 10.1093/jnci/djq457
By:
- Joong Sup Shim;
- Matsui, Yoshiyuki;
- Bhat, Shridhar;
- Nacev, Benjamin A.;
- Jing Xu;
- Bhang, Hyo-eun C.;
- Dhara, Surajit;
- Kee Chung Han;
- Chong, Curtis R.;
- Pomper, Martin G.;
- So, Alan;
- Liu, Jun O.
Publication type:
Article
Pancreatic Cancer: Will Incremental Advances Begin To Make a Difference?
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1821, doi. 10.1093/jnci/djq521
By:
- Hotzman, David C.
Publication type:
Article
Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1874, doi. 10.1093/jnci/djq443
By:
- Metcalfe, Kelly;
- Lubinski, Jan;
- Lynch, Henry T.;
- Ghadirian, Parviz;
- Foulkes, William D.;
- Kim-Sing, Charmaine;
- Neuhausen, Susan;
- Tung, Nadine;
- Rosen, Barry;
- Gronwald, Jacek;
- Ainsworth, Peter;
- Sweet, Kevin;
- Eisen, Andrea;
- Ping Sun;
- Narod, Steven A.
Publication type:
Article
EDITORIAL BOARD.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq545
Publication type:
Article
Medicare Reimbursement and Prescribing Hormone Therapy for Prostate Cancer.
Published in:
2010
By:
- Keating, Nancy L.
Publication type:
Editorial
Re: The Role of SATB1 in Breast Cancer Pathogenesis.
Published in:
2010
By:
- KOHWI-SHIGEMATSU, TERUMI;
- HYE-JUNG HAN;
- RUSSO, JOSE;
- KOHWI, YOSHINORI
Publication type:
Letter
StatBite U.S. Pancreatic Cancer Rates.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1822, doi. 10.1093/jnci/djq517
Publication type:
Article
JAPANESE JOURNAL OF CLINICAL ONCOLOGY.
Published in:
2010
Publication type:
Table of Contents
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1835, doi. 10.1093/jnci/djq442
By:
- Elmets, Craig A.;
- Viner, Jaye L.;
- Pentland, Alice P.;
- Cantrell, Wendy;
- Hui-Yi Lin;
- Bailey, Howard;
- Sewon Kang;
- Linden, Kenneth G.;
- Heffernan, Michael;
- Duvic, Madeleine;
- Richmond, Ellen;
- Elewski, Boni E.;
- Umar, Asad;
- Bell, Walter;
- Gordon, Gary B.
Publication type:
Article
We wish to thank the following reviewers for their generous assistance in evaluating manuscripts submitted to the Journal of the National Cancer Institute during the past year.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1882, doi. 10.1093/jnci/djq459
Publication type:
Article
Chemoprevention, Risk Reduction, Therapeutic Prevention, or Preventive Therapy?
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1815, doi. 10.1093/jnci/djq466
By:
- Meyskens Jr., Frank L.;
- McLaren, Christine E.
Publication type:
Article
TABLE OF CONTENTS.
Published in:
2010
Publication type:
Table of Contents
Meta-analysis: Should It be More Than the Sum of Its Parts?
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1817, doi. 10.1093/jnci/djq469
By:
- Herbolsheimer, Pia;
- Swain, Sandra M.
Publication type:
Article
Targeted Epigenetic Therapies: The Next Frontier?
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1824, doi. 10.1093/jnci/djq520
By:
- Tuma, Rabiya S.
Publication type:
Article
Celecoxib May Be Effective in Preventing Nonmelanoma Skin Cancers.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq523
Publication type:
Article
Cover.
Published in:
JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq547
Publication type:
Article